Biological molecules, such as proteins, peptides and monoclonal antibodies, are widely used as safe, effective, and tailored treatments for a number of diseases, but producing them involves number of steps, from production in cells (often mammalian cells) through to separation, purification and formulation. Traditionally, these biomolecules have been produced in stainless-steel systems which have been fixed into walls and floors, making movement of these systems impossible at worst and difficult at best. The fact that each system needs to be cleaned and sterilized when moving to a new production increases the amount of time between manufacturing runs and requires many resources in order to qualify and clean. This is the old way of production and in order to increase speed and reproducibility, many manufacturers are moving to Single Use technologies.Why should we care?
As the biopharmaceutical industry matures, improving manufacturing efficiency is taking on increasing importance. Single-use systems have made manufacturing not only more convenient but also more efficient, the manufacturing more reproducible and sustainable. Single use systems will therefore have a substantial impact on the future of conventional therapies. In addition, this technological advance will finally allow for the cost-effective production of orphan and personalized medicine, something that the industry is striving considering the recent changes in Breakthrough Medicines at the Agency.
Learn more about the impact Single-Use Technologies is having in:
- • Increasing the Speed of Bioprocessing
- • Cost Cutting
- • Flexible Processing Conditions
- • Quality, Reproducibility and Compatibility
Download the Free eBook - Single Use Technology: From bioprocess convenience to drug-development driver today.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment